{"doi":"10.1158\/0008-5472.CAN-04-1367","coreId":"135942","oai":"oai:bradscholars.brad.ac.uk:10454\/3967","identifiers":["oai:bradscholars.brad.ac.uk:10454\/3967","10.1158\/0008-5472.CAN-04-1367"],"title":"Fas signaling is involved in the control of hair follicle response to chemotherapy.","authors":["Sharov, Andrei A.","Siebenhaar, F.","Sharova, T.Y.","Botchkareva, Natalia V.","Gilchrest, Barbara A.","Botchkarev, Vladimir A."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2004","abstract":"NoChemotherapeutic agents induce p53-dependent apoptosis in the hair follicle (HF) resulting in hair loss, a common side effect of cancer therapy. Here, we show that Fas as a p53 target plays important role in the HF response to cyclophosphamide. Specifically, we demonstrate that Fas is up-regulated in HF keratinocytes after cyclophosphamide treatment, Fas ligand-neutralizing antibody partially inhibits HF response to cyclophosphamide in wild-type mice, and Fas knockout mice show significant retardation of cyclophosphamide-induced HF involution associated with reduced Fas-associated death domain and caspase-8 expression. These data raise a possibility to explore blockade of Fas signaling as a part of complex local therapy for inhibiting keratinocyte apoptosis and hair loss induced by chemotherapy","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":null,"rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/3967<\/identifier><datestamp>\n                2016-08-18T17:13:25Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nFas signaling is involved in the control of hair follicle response to chemotherapy.<\/dc:title><dc:creator>\nSharov, Andrei A.<\/dc:creator><dc:creator>\nSiebenhaar, F.<\/dc:creator><dc:creator>\nSharova, T.Y.<\/dc:creator><dc:creator>\nBotchkareva, Natalia V.<\/dc:creator><dc:creator>\nGilchrest, Barbara A.<\/dc:creator><dc:creator>\nBotchkarev, Vladimir A.<\/dc:creator><dc:subject>\nFas antigen<\/dc:subject><dc:subject>\nAntineoplastic agent<\/dc:subject><dc:subject>\nTreatment<\/dc:subject><dc:subject>\nChemotherapy<\/dc:subject><dc:subject>\nHair follicle<\/dc:subject><dc:subject>\nRegulation(control)<\/dc:subject><dc:subject>\nSignal transduction<\/dc:subject><dc:description>\nNo<\/dc:description><dc:description>\nChemotherapeutic agents induce p53-dependent apoptosis in the hair follicle (HF) resulting in hair loss, a common side effect of cancer therapy. Here, we show that Fas as a p53 target plays important role in the HF response to cyclophosphamide. Specifically, we demonstrate that Fas is up-regulated in HF keratinocytes after cyclophosphamide treatment, Fas ligand-neutralizing antibody partially inhibits HF response to cyclophosphamide in wild-type mice, and Fas knockout mice show significant retardation of cyclophosphamide-induced HF involution associated with reduced Fas-associated death domain and caspase-8 expression. These data raise a possibility to explore blockade of Fas signaling as a part of complex local therapy for inhibiting keratinocyte apoptosis and hair loss induced by chemotherapy.<\/dc:description><dc:date>\n2009-11-24T10:11:39Z<\/dc:date><dc:date>\n2009-11-24T10:11:39Z<\/dc:date><dc:date>\n2004<\/dc:date><dc:type>\nArticle<\/dc:type><dc:type>\nNo full-text available in the repository<\/dc:type><dc:identifier>\nSharov, A.A., Siebenhaar, F., Sharova, T.Y., Botchkareva, N.V. and Gilchrist, B.A.(2004).  Fas signaling is involved in the control of hair follicle response to chemotherapy.   Cancer Research. Vol. 64, No. 17, pp. 6266-6270.<\/dc:identifier><dc:identifier>\n90016261<\/dc:identifier><dc:identifier>\n90017919<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/3967<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-04-1367<\/dc:relation>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-04-1367"],"year":2004,"topics":["Fas antigen","Antineoplastic agent","Treatment","Chemotherapy","Hair follicle","Regulation(control)","Signal transduction"],"subject":["Article","No full-text available in the repository"],"fullText":null}